Active Clinical Trials
Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.
- Sort by Sort ascending
- Study title
- Condition
- Phase
- Location
- NCT ID
| Study title | Condition | Phase | Location | NCT ID |
|---|---|---|---|---|
|
Assessing Short-term Treatment Satisfaction and Quality of Life in Patients With Hidradenitis Suppurativa Initiated on Secukinumab. |
Hidradenitis Suppurativa | United Arab Emirates | NCT06785675 | |
|
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy |
Prostate Cancer | Phase2, Phase3 |
Australia Brazil China Israel Japan Singapore South Korea Taiwan United States View all
|
NCT06780670 |
|
A Study of JSB462 (Luxdegalutamide) Plus Lutetium (177Lu) Vipivotide Tetraxetan in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC) |
Prostatic Cancer, Castration-Resistant | Phase2 |
Australia Austria Canada China Czechia France Germany Israel Italy Netherlands Singapore South Korea Spain Taiwan United States View all
|
NCT07047118 |
|
Real-world Study on Secukinumab Effectiveness in Biologic-naïve Ankylosing Spondylitis (AS) Patients in Korea. |
Ankylosing Spondylitis | South Korea | NCT06905288 | |
|
A Study to Evaluate the Efficacy and Safety of QMF149 (Indacaterol Acetate/Mometasone Furoate) Versus Budesonide in Children From 6 to Less Than 12 Years of Age With Asthma |
Asthma | Phase3 |
Argentina Austria Bulgaria Colombia Czechia Greece Guatemala Hungary Italy Mexico Panama Portugal Romania South Africa Spain Vietnam View all
|
NCT05562466 |
|
Study of Remibrutinib (LOU064) Efficacy and Safety and Exploration of Its Mechanism of Action in Participants With Chronic Urticaria |
Chronic Urticaria (CU): Chronic Inducible Urticaria (CINDU) and Chronic Spontaneous Urticaria (CSU) | Phase2 |
France Germany Poland Spain United States View all
|
NCT06865651 |
|
Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy. |
C3G | Phase3 |
Brazil Canada China France Germany Greece India Israel Italy Japan Netherlands Spain Switzerland Turkey (Türkiye) United Kingdom United States View all
|
NCT04817618 |
|
DFT383 in Pediatric Participants With Nephropathic Cystinosis |
Nephropathic Cystinosis | Phase1, Phase2 | United States | NCT06910813 |
|
A Study to Identify an Optimal Dose of QCZ484 in Mild to Moderate Hypertensive Patients |
Hypertension | Phase2 |
Japan Singapore United States |
NCT06857955 |
|
Safety, Efficacy and Tolerability of Ianalumab Versus Placebo, Combination With SoC Therapy, in Participants With Active Lupus Nephritis |
Lupus Nephritis | Phase3 |
Argentina Brazil Canada Colombia Estonia France Germany Guatemala Hong Kong Hungary India Italy Lithuania Malaysia Mexico Romania Singapore South Korea Spain Taiwan United Kingdom United States View all
|
NCT05126277 |